WS02.3 Randomized, double-blind (DB), placebo-controlled...

Journal of Cystic Fibrosis 2015 / 06 Vol. 14

WS02.3 Randomized, double-blind (DB), placebo-controlled study and open-label (OL) extension of liposomal amikacin for inhalation (LAI) in patients with refractory nontuberculous mycobacterial (NTM) lung disease (LD)

Olivier, K.N., Eagle, G., McGinnis, J.P., Micioni, L., Daley, C.L., Winthrop, K.L., Ruoss, S., Addrizzo-Harris, D.J., Flume, P., Dorgan, D., Salathe, M., Brown-Elliott, B.A., Wallace, R., Griffith, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Language:
english
Journal:
Journal of Cystic Fibrosis
DOI:
10.1016/S1569-1993(15)30009-6
Date:
June, 2015
File:
PDF, 72 KB
english, 2015
Conversion to is in progress
Conversion to is failed